Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5631611

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCCCCCCCSSCCCCCCOP(=O)(O)CO[C@H](CO)Cn1ccc(N)nc1=O.N

Basic Information

ChEMBL ID CHEMBL5631611
Phase Preclinical
Structure Type MOL
InChI Key PFESLSOTFVQIME-BDQAORGHSA-N
Parent Compound CHEMBL6068745
Active Moiety CHEMBL6068745
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names

Molecular Properties

539.7
MW (Da)
4.66
ALogP
10
HBA
3
HBD
136.9
PSA (Ų)
0.11
QED
1
Ro5 Violations
22
Rot. Bonds

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C22H45N4O6PS2
MW 556.73
Aromatic Rings 1
Heavy Atoms 34
NP-Likeness 0.31

Activity Summary

IC50 1 meas. best 4.31

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Vaccinia virus
CHEMBL613493
IC50 4.31 4.31 49340.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Vaccinia virus IC50 = 49340.0 nM 4.31 Antiviral activity against VACV infected in Vero cells assessed as reduction in ... 37390509

Literature References

PubMed DOI Target Context # Activities
37390509 10.1016/j.ejmech.2023.115601 ADMET 3
37390509 10.1016/j.ejmech.2023.115601 Vaccinia virus 2
37390509 10.1016/j.ejmech.2023.115601 A549 1

Data from ChEMBL 36 via Core Engine